These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 34487299)

  • 1. Digging into the lesser-known aspects of CRISPR biology.
    Guzmán NM; Esquerra-Ruvira B; Mojica FJM
    Int Microbiol; 2021 Nov; 24(4):473-498. PubMed ID: 34487299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral diversity threshold for adaptive immunity in prokaryotes.
    Weinberger AD; Wolf YI; Lobkovsky AE; Gilmore MS; Koonin EV
    mBio; 2012 Dec; 3(6):e00456-12. PubMed ID: 23221803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas systems: beyond adaptive immunity.
    Westra ER; Buckling A; Fineran PC
    Nat Rev Microbiol; 2014 May; 12(5):317-26. PubMed ID: 24704746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas: evolution of an RNA-based adaptive immunity system in prokaryotes.
    Koonin EV; Makarova KS
    RNA Biol; 2013 May; 10(5):679-86. PubMed ID: 23439366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Biology of CRISPR-Cas: Backward and Forward.
    Hille F; Richter H; Wong SP; Bratovič M; Ressel S; Charpentier E
    Cell; 2018 Mar; 172(6):1239-1259. PubMed ID: 29522745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas systems: role in cellular processes beyond adaptive immunity.
    Devi V; Harjai K; Chhibber S
    Folia Microbiol (Praha); 2022 Dec; 67(6):837-850. PubMed ID: 35854181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology.
    Ishino Y; Krupovic M; Forterre P
    J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29358495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptation in CRISPR-Cas Systems.
    Sternberg SH; Richter H; Charpentier E; Qimron U
    Mol Cell; 2016 Mar; 61(6):797-808. PubMed ID: 26949040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unravelling the structural and mechanistic basis of CRISPR-Cas systems.
    van der Oost J; Westra ER; Jackson RN; Wiedenheft B
    Nat Rev Microbiol; 2014 Jul; 12(7):479-92. PubMed ID: 24909109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adapting to new threats: the generation of memory by CRISPR-Cas immune systems.
    Heler R; Marraffini LA; Bikard D
    Mol Microbiol; 2014 Jul; 93(1):1-9. PubMed ID: 24806524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type II anti-CRISPR proteins as a new tool for synthetic biology.
    Zhang Y; Marchisio MA
    RNA Biol; 2021 Aug; 18(8):1085-1098. PubMed ID: 32991234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas: Complex Functional Networks and Multiple Roles beyond Adaptive Immunity.
    Faure G; Makarova KS; Koonin EV
    J Mol Biol; 2019 Jan; 431(1):3-20. PubMed ID: 30193985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas Systems in Prokaryotes.
    Burmistrz M; Pyrć K
    Pol J Microbiol; 2015; 64(3):193-202. PubMed ID: 26638527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies.
    Newsom S; Parameshwaran HP; Martin L; Rajan R
    Front Cell Infect Microbiol; 2020; 10():619763. PubMed ID: 33585286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unity among the diverse RNA-guided CRISPR-Cas interference mechanisms.
    Ganguly C; Rostami S; Long K; Aribam SD; Rajan R
    J Biol Chem; 2024 Jun; 300(6):107295. PubMed ID: 38641067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type II Anti-CRISPR Proteins.
    Hwang S; Maxwell KL
    J Mol Biol; 2023 Apr; 435(7):168041. PubMed ID: 36893938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SnapShot: CRISPR-RNA-guided adaptive immune systems.
    Carter J; Wiedenheft B
    Cell; 2015 Sep; 163(1):260-260.e1. PubMed ID: 26406380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type IV CRISPR-Cas systems are highly diverse and involved in competition between plasmids.
    Pinilla-Redondo R; Mayo-Muñoz D; Russel J; Garrett RA; Randau L; Sørensen SJ; Shah SA
    Nucleic Acids Res; 2020 Feb; 48(4):2000-2012. PubMed ID: 31879772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas systems in oral microbiome: From immune defense to physiological regulation.
    Gong T; Zeng J; Tang B; Zhou X; Li Y
    Mol Oral Microbiol; 2020 Apr; 35(2):41-48. PubMed ID: 31995666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unprecedented Diversity of Unique CRISPR-Cas-Related Systems and Cas1 Homologs in Asgard Archaea.
    Makarova KS; Wolf YI; Shmakov SA; Liu Y; Li M; Koonin EV
    CRISPR J; 2020 Jun; 3(3):156-163. PubMed ID: 33555973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.